LIMN Stock Performance and Key Statistics

LIMN has a current P/E ratio of -0.32

The LIMN stock has a trailing twelve month price-to sales (P/S) ratio of N/A while its price-to-book (P/B) value is -23.41.

LIMN's price-to-free-cashflow (P/FCF) ratio is -0.29, an indicator that is currently being trending upward.

Based on LIMN's recent bid, its distance from 20 days simple moving average is -67.56%. It is -68.19% apart from 50 days simple moving average, and it is -94.14% apart from 200 days simple moving average.

The 52-week high for LIMN is $10.75 which is -99.32% away from the current price level whereas the distance of that from the 52-week low of $0.10 stands at 9.48%.

The performance of LIMN stock was not encouraging with most of its significant price indicators in green. Liminatus Pharma, Inc. Class A Common Stock(NASDAQ: LIMN) shares have moved upward +3.99% or $0.00 in the latest trading session and have gained 19.67% year-to-date (YTD). The stock has lost nearly -93.05% over the past year. After moving -36.52% over the trailing 3-month period, the stock is -86.92% lower in the 6-month period. Looking at its performance over the shorter term, it'slost -5.21% a week and -6.3% a month.

The current 14-day RSI for LIMN stock is 36.82. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.

ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, Liminatus Pharma, Inc. Class A Common Stock (LIMN) has a 14-day ATR of 0.23.

After closing at $0.11 with 26.83M of its shares outstanding, the current enterprise value of LIMN is roughly -.

Liminatus Pharma, Inc. Class A Common Stock (NASDAQ: LIMN) is down -93.05% when it comes to the percentage price change over the past 52-weeks. The percentage price change came less than that of broader S&P 500 index that came at a fall of 6.06%. LIMN stock price is also up 19.67% on its value in year-to-date trading.

The number outstanding shares of LIMN is 26.83M, and of these 46.02% shares are freely available for trading. On average, LIMN stock has traded 17.28M shares per day for the past 10 days. A total of 22.83M shares changed hands during the last trading session with the average session volume of 11.4M shares.